The development of artemisinin resistance in malaria: Reasons and solutions

Phytotherapy Research

Volumn 24, Issue 7, 2010, Pages 1104-1106

  Chrubasik, Cosima ^a   Jacobson, Raymond L ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Artemisinin based therapy; Malaria; Resistance; Vaccination

Indexed keywords

ARTEMISININ; HERBACEOUS AGENT;

ARTICLE; COMBINATION CHEMOTHERAPY; HUMAN; MALARIA; MIGRANT BIRD; MONOTHERAPY; PLASMODIUM FALCIPARUM;

ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 77954518952     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3133     Document Type: Article

References (14)

1. Breman JG. 2009. Eradicating malaria. Sci Prog 92: 1-38.
2. Campagna AM, Patnaik MM. 2009. Advances in global biotechnology and local resources to treat malaria. Minn Med 92: 44-45.
3. Croft AM, Garner P. 2008. WITHDRAWN: Mefloquine for preventing malaria in non-immune adult travellers. Cochrane Database Syst Rev Jan 23; (1): CD000138.
4. De Ridder S, van der Kooy F, Verpoorte R. 2008. Artemisia annua as a self-reliant treatment for malaria in developing countries. J Ethnopharmacol 120: 302-314.
5. Goodman C, Coleman P, Mills A. 1999. Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet 354: 378-385.
6. Graves P, Gelband H. 2007. WITHDRAWN: Vaccines for preventing malaria. Cochrane Database Syst Rev Jul 18; (4): CD000129.
7. Ioset JR, Kaur H. 2009. Simple field assays to check quality of current artemisinin-based antimalarial combination formulations. PLoS One 4: e7270.
8. Jambou R, Legrand E, Niang M et al. 2005. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 366(9501): 1960-1963.
9. Krettli AU, Andrade-Neto VF, Brandão MG, Ferrari WM. 2001. The search for new antimalarial drugs from plants used to treat fever and malaria or plants randomly selected: a review. Mem Inst Oswaldo Cruz 96: 1033-1042.
10. Nakato H, Vivancos R, Hunter PR. 2007. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria. J Antimicrob Chemother 60: 929-936.
11. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359: 2619-2620.
12. Pongtavornpinyo W, Yeung S, Hastings IM, Dondorp AM, Day NP, White NJ. 2008. Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies. Malar J 7: 229.
13. Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. 2009. Artemisinin- based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev (3): CD007483.
14. Woitsch B, Wernsdorfer G, Prajakwong S, Rojanawatsirivet C, Kollaritsch H, Wernsdorfer WH. 2004. Comparative study of the in vitro sensitivity of Plasmodium falciparum to artemisinin in two border areas of Thailand. Wien Klin Wochenschr 116 (Suppl 4): 35-40. (Pubitemid 40065994)